ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,354, issued on Jan. 27, was assigned to ChemoCentryx Inc. (Thousand Oaks, Calif.).
"Triaryl compounds for treatment of PD-L1 diseases" was invented by Pingchen Fan (Hayward, Calif.), Christopher Lange (Hayward, Calif.), Venkat Reddy Mali (Cupertino, Calif.), Darren J. McMurtrie (Sunnyvale, Calif.), Viengkham Malathong (Mountain View, Calif.), Sreenivas Punna (Sunnyvale, Calif.), Rajinder Singh (Belmont, Calif.), Ju Yang (Palo Alto, Calif.), Yibin Zeng (Foster City, Calif.) and Penglie Zhang (Foster City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds are provided that are useful as immunomodulators. The compounds have the Formula (I...